Ambeed.cn

首页 / 抑制剂/激动剂 / 表观遗传学 / 组蛋白甲基转移酶 / OICR-9429

OICR-9429 {[allProObj[0].p_purity_real_show]}

货号:A225196

OICR-9429 is an antagonist of the interaction of WDR5 with peptide regions of MLL and Histone 3.

OICR-9429 化学结构 CAS号:1801787-56-3
OICR-9429 化学结构
CAS号:1801787-56-3
OICR-9429 3D分子结构
CAS号:1801787-56-3
OICR-9429 化学结构 CAS号:1801787-56-3
OICR-9429 3D分子结构 CAS号:1801787-56-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

OICR-9429 纯度/质量文件 产品仅供科研

货号:A225196 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

更多 >
产品名称 Histone Methyltransferase 其他靶点 纯度
BRD4770 99%+
UNC1999 +++

EZH1, IC50: 45 nM

EZH2, IC50: 2 nM

99%+
EPZ005687 ++

EZH2, Ki: 24 nM

98+%
EPZ015666 +++

PRMT5, Ki: 5 nM

99%+
3-Deazaneplanocin A HCl ++++

S-adenosylhomocysteine hydrolase, Ki: 50 pM

99%+
Tazemetostat +++

EZH2, Ki: 2.5 nM

EZH2, IC50: 11 nM

98%
GSK126 ++

EZH2, IC50: 9.9 nM

99%+
MI-3 +

Menin-MLL, IC50: 648 nM

98%
MM-102 ++

MLL1, IC50: 0.4 μM

99%
EI1 ++

Ezh2 (wild-type), IC50: 15 nM

EZH2 (Y641F), IC50: 13 nM

99% (HPLC)
SGC0946 ++++

DOT1L, IC50: 0.3 nM

99%+
PFI-2 HCl ++++

SETD7, Ki: 0.33 nM

SETD7, IC50: 2 nM

99%+
Pinometostat ++++

DOT1L, Ki: 80 pM

99%+
EPZ004777 +++

DOT1L, IC50: 0.4 nM

99%+
Entacapone ++

COMT, IC50: 151 nM

95%
UNC0379 +

SETD8, IC50: 7.9 μM

99%+
Menin-MLL inhibitor MI-2 +

Menin-MLL, IC50: 446 nM

98%
GSK343 +++

EZH1, IC50: 240 nM

EZH2, IC50: 4 nM

99%+
BIX-01294 3HCl +

G9a, IC50: 2.7 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

OICR-9429 生物活性

描述 OICR-9429 is a potent and selective antagonist of the WDR5-MLL1 interaction with KD value of 30nM[6]. OICR-9429 binds to WDR5 with high affinity and competitively disrupts its interaction with a high-affinity Wdr5-INteracting (WIN) peptide of MLL. It disrupted the C/EBPα p30-Wdr5 interaction at 10μM. OICR-9429 selectively inhibited proliferation and induced differentiation in p30-expressing human AML cells and induced the up-regulation of myeloid marker genes in Cebpap30/p30 cells, such as C3ar1, Ccl9, Lcn2, Lilrb3, and Lyz2, at 20μM[5].
作用机制 OICR-9429 binds in the arginine binding site of WDR5, occupying the MLL-binding pocket of Wdr5.[5]

OICR-9429 动物研究

Dose Mice: 1.5 mg/kg[3] (i.p.), 3 mg/kg[4] (i.p.), 30 mg/kg[1] (i.p.); 3 mg/kg[1] (i.v.)
Administration i.p.
Pharmacokinetics
Animal Mice[1]
Dose 3 mg/kg (i.v.)
30 mg/kg (i.p.)
Administration i.v.
i.p.
F 67% (i.p.)
Vd 15.6 L/kg (i.v.)
T1/2 287 min (i.v.)
Tmax 5 min (i.v.)
15 min (i.p.)
CL 3233 ml/h/kg (i.v.)
Cmax 697 ng/ml (i.v.)
3790 ng/ml (i.p.)
AUC 1012 h·ng/ml (i.v.)
6813 h·ng/ml (i.p.)

OICR-9429 参考文献

[1]Getlik M, Smil D, et al. Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). J Med Chem. 2016 Mar 24;59(6):2478-96.

[2]Grebien F, Vedadi M, et al. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. Nat Chem Biol. 2015 Aug;11(8):571-578.

[3]Shimoda H, Doi S, et al. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16INK4a. Kidney Int. 2019 Nov;96(5):1162-1175.

[4]Cao L, Wu G, et al. Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis. Nat Commun. 2019 Aug 21;10(1):3761.

[5]Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, Skucha A, Vittori S, Kuznetsova E, Smil D, Barsyte-Lovejoy D, Li F, Poda G, Schapira M, Wu H, Dong A, Senisterra G, Stukalov A, Huber KVM, Schönegger A, Marcellus R, Bilban M, Bock C, Brown PJ, Zuber J, Bennett KL, Al-Awar R, Delwel R, Nerlov C, Arrowsmith CH, Superti-Furga G. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. Nat Chem Biol. 2015 Aug;11(8):571-578. doi: 10.1038/nchembio.1859. Epub 2015 Jul 13. Erratum in: Nat Chem Biol. 2015 Oct;11(10):815. PMID: 26167872; PMCID: PMC4511833.

[6]Getlik M, Smil D, Zepeda-Velázquez C, Bolshan Y, Poda G, Wu H, Dong A, Kuznetsova E, Marcellus R, Senisterra G, Dombrovski L, Hajian T, Kiyota T, Schapira M, Arrowsmith CH, Brown PJ, Vedadi M, Al-Awar R. Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). J Med Chem. 2016 Mar 24;59(6):2478-96. doi: 10.1021/acs.jmedchem.5b01630. Epub 2016 Mar 9. PMID: 26958703.

OICR-9429 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.80mL

0.36mL

0.18mL

9.00mL

1.80mL

0.90mL

18.00mL

3.60mL

1.80mL

OICR-9429 技术信息

CAS号1801787-56-3
分子式C29H32F3N5O3
分子量 555.59
SMILES Code O=C(C(C(C(F)(F)F)=C1)=CNC1=O)NC2=CC(C3=CC=CC(CN4CCOCC4)=C3)=CC=C2N5CCN(C)CC5
MDL No. MFCD28411621
别名
运输蓝冰
InChI Key DJOVLOYCGXNVPI-UHFFFAOYSA-N
Pubchem ID 91623360
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry, 2-8°C

溶解方案 请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。